Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,020 | 260 | 570 | 1,580 | 3,110 |
| Receivables | 680 | 130 | 910 | 820 | 410 |
| Inventories | 0 | 8 | 90 | 290 | 260 |
| Other current assets | 30 | 72 | 350 | 270 | 100 |
| TOTAL | $1,730 | $470 | $1,920 | $2,960 | $3,880 |
| Non-Current Assets | |||||
| PPE Net | 130 | 180 | N/A | N/A | N/A |
| Other Non-Current Assets | 240 | 230 | 650 | 550 | 240 |
| TOTAL | $370 | $410 | $650 | $550 | $240 |
| Total Assets | $2,110 | $890 | $3,160 | $4,140 | $4,410 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 230 | 330 | 650 | 400 | 180 |
| Accrued Expenses | 340 | 450 | 410 | 330 | 200 |
| Other current liabilities | 420 | 780 | N/A | 110 | 320 |
| TOTAL | $1,340 | $2,440 | $1,640 | $870 | $720 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,340 | $2,440 | $1,640 | $870 | $720 |
| Shareholders' Equity | |||||
| Common Shares | 460 | 250 | 210 | 190 | 170 |
| Retained earnings | -45,600 | -45,960 | -40,170 | -35,450 | -10,050 |
| Other shareholders' equity | -10 | 10 | 0 | 0 | 0 |
| TOTAL | $760 | $-1,550 | $1,520 | $3,260 | $3,690 |
| Total Liabilities And Equity | $2,100 | $890 | $3,160 | $4,130 | $4,410 |